• slidebg1
    Your reliable, fully U.S. based
    manufacturing partner
    of choice
  • Experts in complex drug
    development and
    commercialization
  • Our motto is “execution with
    precision” and absolutely no
    compromise on quality

About Company

Appco Pharma LLC

Appco Pharma LLC endeavors to be one of the leading pharmaceutical companies in the US by introducing high quality and affordable drug products.

The Company was incorporated in Apr ‘2012 with its key business location at 120 Belmont Dr., Somerset NJ. This site hosts the Unit I manufacturing and development area and is inspected and approved United States Food and Drug Administration (USFDA).

The Company also operates another manufacturing facility Unit II located at 262 Old New Brunswick Road Suite “N” Piscataway, NJ. The Unit II is also inspected and approved by USFDA.

Between Unit I and Unit II, the Company employs around 90 professionals focusing on pharmaceutical drug development, testing, manufacturing and packing operations.

service-image

We Offer Services / Operations

Our technologically advanced GMP laboratories specialize in providing the following services:

feature-img

Product Development
Services

Pre-formulation studies Pharmacovigilance IP evaluation

Read More

feature-img

Formulation Development
Services

Immediate & Controlled Release Oral Solid Dosage Forms Bi-layered Tablets

Read More

feature-img

Manufacturing
Services

High & Low Shear Granulation Direct compression Roller compaction

Read More

feature-img

Analytical Development
& Validation

Analytical method, Forced degradation studies, Cleaning method

Read More

News & Events

RECEIVED FINAL APPROVAL FOR MODAFINIL TABLET

Modafinil tablet is a Rx drug indicated for the treatment of wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD).

RECEIVED TENTATIVE APPROVAL FOR SILDENAFIL TABLET

Sildenafil tablet is a Rx drug indicated for the treatment of erectile dysfunction and pulmonary arterial hypertension (WHO Group I) in adults to improve exercise ability.

Received final approval for Zolmitriptan Tablet

Zolmitriptan tablet is a Rx drug indicated for acute treatment of migraine with or without aura in adults.

Received final approval for Budesonide Capsule

Budesonide capsule is a Rx drug indicated for the treatment of mild to moderate Active Crohn's Disease.

Received final approval for Glycopyrrolate Tablet

Glycopyrrolate tablet is a Rx drug indicated for the treatment of peptic ulcers.

Received final approval for Cyproheptadine HCl Tablet

Cyproheptadine HCl tablet is a Rx drug indicated for the treatment of perennial and seasonal allergic rhinitis.